Leukemia, Eosinophilic, Acute
Showing 1 - 25 of >10,000
Adult Acute Basophilic Leukemia, Adult Acute Eosinophilic Leukemia, Adult Acute Megakaryoblastic Leukemia (M7) Trial in Atlanta,
Terminated
- Adult Acute Basophilic Leukemia
- +16 more
- eltrombopag olamine
- standard follow-up care
-
Atlanta, Georgia
- +1 more
Jul 20, 2022
Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Basophilic Leukemia, Adult
Active, not recruiting
- Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome
- +18 more
- eltrombopag olamine
-
Cleveland, OhioCase Comprehensive Cancer Center
Nov 29, 2021
Myelofibrosis, Chronic Myelomonocytic Leukemia Trial in Canada, United States (SL-401)
Active, not recruiting
- Myelofibrosis
- Chronic Myelomonocytic Leukemia
-
Duarte, California
- +9 more
Jan 24, 2023
Adult Acute Basophilic Leukemia, Adult Acute Eosinophilic Leukemia, Adult Acute Megakaryoblastic Leukemia (M7) Trial in United
Completed
- Adult Acute Basophilic Leukemia
- +16 more
-
Little Rock, Arkansas
- +53 more
Jan 13, 2022
Childhood Acute Basophilic Leukemia, Childhood Acute Eosinophilic Leukemia, Childhood Acute Erythroleukemia (M6) Trial in
Completed
- Childhood Acute Basophilic Leukemia
- +14 more
- asparaginase
- +5 more
-
Phoenix, Arizona
- +96 more
Jan 20, 2022
Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in
Active, not recruiting
- Accelerated Phase Chronic Myelogenous Leukemia
- +125 more
- tetanus-CMV fusion peptide vaccine
- laboratory biomarker analysis
-
Duarte, CaliforniaCity of Hope Medical Center
Feb 28, 2022
Acute Myeloid Leukemia Trial in Antalya
Recruiting
- Acute Myeloid Leukemia
-
Antalya, TurkeyAntalya Training and Research Hospital
Jul 29, 2023
Patients With Acute Myeloid Leukemia
Recruiting
- Acute Myeloid Leukemia, Adult
-
Freiburg, CA, GermanyMedical Center- University of Freiburg
Aug 4, 2023
Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, in Relapse Trial in Xuzhou (anti Tim-3/CD123 CAR-T cell therapy)
Recruiting
- Acute Myeloid Leukemia Refractory
- Acute Myeloid Leukemia, in Relapse
- anti Tim-3/CD123 CAR-T cell therapy
-
Xuzhou, Jiangsu, ChinaKailin Xu
Nov 4, 2023
The Relapses in Childhood Acute Lymphoplastic Leukemia Excluding
Completed
- Leukemia, Acute
- (no location specified)
Jul 23, 2023
Frequency and Risk Factors of Acute Myeloid Leukemia
Not yet recruiting
- Myeloid Leukemia
- Bone marrow aspirite for diagnosis
- (no location specified)
Mar 15, 2023
Acute Myeloid Leukemia, Blastic Plasmacytoid Dendritic Cell Tumor (BPDCN), Relapse Leukemia Trial in Taiyuan (CD123 targeted
Recruiting
- Acute Myeloid Leukemia
- +3 more
- CD123 targeted CAR-NK cells
-
Taiyuan, Shanxi, ChinaShanxi Bethune Hospital
Aug 28, 2023
H19 in Acute Lymphoblastic Leukemia.
Not yet recruiting
- Acute Lymphoid Leukemia
- (no location specified)
Jul 11, 2023
Acute Myeloid Leukemia Trial in Beijing (Ven+CAG)
Recruiting
- Acute Myeloid Leukemia
-
Beijing, Beijing, ChinaPeking University People's Hospital
Jun 23, 2023
Relapsed Adult ALL, Relapsed Adult AML Trial in Changchun (Plerixafor)
Active, not recruiting
- Relapsed Adult ALL
- Relapsed Adult AML
-
Changchun, Jilin, ChinaFirst Hospital of Jilin University
Nov 19, 2023
Acute Myeloid Leukemia Refractory Trial in Lyon (NP137, Azacitidine Injection, Venetoclax)
Recruiting
- Acute Myeloid Leukemia Refractory
- NP137
- +2 more
-
Lyon, FranceCentre Léon Bérard
Nov 30, 2023
Acute Myeloid Leukemia Trial in Tianjin (Mitoxantrone HCl liposome injection, Cytarabine, Homoharringtonine)
Not yet recruiting
- Acute Myeloid Leukemia
- Mitoxantrone hydrochloride liposome injection
- +3 more
- (no location specified)
May 29, 2023
Acute Myeloid Leukemia Trial in Tianjin (Mitoxantrone HCl liposome injection, Cytarabine, Homoharringtonine)
Not yet recruiting
- Acute Myeloid Leukemia
- Mitoxantrone hydrochloride liposome injection
- +3 more
-
Tianjin, ChinaInstitute of Hematology & Blood Diseases Hospital
Jul 1, 2023
Acute Lymphoblastic Leukemia, in Relapse, Acute Lymphoblastic Leukemia With Failed Remission Trial in São Paulo (Bortezomib)
Not yet recruiting
- Acute Lymphoblastic Leukemia, in Relapse
- Acute Lymphoblastic Leukemia With Failed Remission
-
São Paulo, SP, BrazilInstituto do Cancer do Estado de Sao Paulo
Sep 12, 2023
B-Cell Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia Trial in Tampa (Tecartus)
Recruiting
- B-Cell Lymphoblastic Leukemia
- Acute Lymphoblastic Leukemia
-
Tampa, FloridaMoffitt Cancer Center
Nov 28, 2023
Oral Azacitidine Maintenance Therapy in Korean Acute Myeloid
Not yet recruiting
- Acute Myeloid Leukemia
- Oral azacitidine
-
Seoul, Korea, Republic ofBristol-Myers Squibb YH
Oct 3, 2023